BioMarin to Host Fourth Quarter and Full-Year 2025 Financial Results Conference Call and Webcast on Monday, February 23, 2026, at 4:30pm ET

Rhea-AI Summary

BioMarin (NASDAQ: BMRN) will host a conference call and webcast on Monday, February 23, 2026 at 4:30 p.m. ET to discuss fourth-quarter and full-year 2025 financial results and provide a business update.

Alexander Hardy, President and CEO, will lead the call. Dial-in numbers, replay details, and a live webcast are available via the company's investor website; a replay will be archived for one week.

Key Figures

Conference date: February 23, 2026 Conference time: 4:30 p.m. ET U.S./Canada dial-in: 800-715-9871 +5 more

8 metrics

Conference date February 23, 2026 Q4 and full-year 2025 results call

Conference time 4:30 p.m. ET Start time for results call and webcast

U.S./Canada dial-in 800-715-9871 Domestic investor access number

International dial-in 646-307-1963 International investor access number

Conference Call ID 4503000 Access code for live call

U.S./Canada replay dial-in 800-770-2030 Replay number available for one week

International replay dial-in 609-800-9909 Replay number available for one week

Replay duration One week Archive period on company website

Market Reality Check

Price: $59.87 Vol: Volume 1,940,924 is at 0....

normal vol

$59.87 Last Close

Volume Volume 1,940,924 is at 0.91x the 20-day average of 2,139,189, indicating typical trading activity ahead of the call. normal

Technical Shares at 59.87 are trading above the 200-day MA of 56.53, suggesting a pre-existing upward bias versus long-term trend.

Peers on Argus

BMRN was modestly lower (-0.12%) while peers were mixed: BBIO -2.97%, IONS -0.71...

BMRN was modestly lower (-0.12%) while peers were mixed: BBIO -2.97%, IONS -0.71%, ASND -0.7% versus EXEL +2.4%, SMMT +1.49%, pointing to stock-specific rather than broad sector movement.

Common Catalyst Upcoming earnings and results calls in biotechnology, as seen with BBIO’s similar earnings date announcement.

Previous Conferences,earnings Reports

5 past events · Latest: Jul 22 (Neutral)

Same Type Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jul 22	Earnings call date	Neutral	+4.7%	Set Q2 2025 results call and webcast hosted by CEO Alexander Hardy.
Apr 17	Earnings call date	Neutral	+0.6%	Announced Q1 2025 financial results call with business update details.
Feb 05	Earnings call date	Neutral	+2.1%	Scheduled Q4 and full-year 2024 results call and general business update.
Oct 16	Earnings call date	Neutral	-0.4%	Announced Q3 2024 financial results call with replay and webcast access.
Jul 23	Earnings call date	Neutral	-1.0%	Set Q2 2024 financial results call and webcast logistics for investors.

Pattern Detected

Past earnings-date conference call announcements for BMRN have generally produced modest single-digit moves in either direction, with no consistent bias up or down.

Recent Company History

Across the last five conferences,earnings scheduling releases from Jul 23, 2024 through Jul 22, 2025, BioMarin regularly announced quarterly results calls hosted by CEO Alexander Hardy at 4:30 p.m. ET. These events typically provided financial updates and business overviews, with subsequent 24-hour share moves ranging from about -1% to +4–5%. Today’s fourth quarter and full-year 2025 call notice continues that established communication pattern.

Historical Comparison

+1.2% avg move · In the past five earnings-date announcements, BMRN saw an average move of 1.18%. The current -0.12% ...

conferences,earnings

+1.2%

Average Historical Move conferences,earnings

In the past five earnings-date announcements, BMRN saw an average move of 1.18%. The current -0.12% change sits at the low end of this historically modest reaction range.

The company has maintained a consistent cadence of quarterly earnings calls from 2024 through 2025, each hosted by the CEO at 4:30 p.m. ET, and this 2025 year-end call notice extends that pattern into 2026.

Market Pulse Summary

This announcement sets the date and access details for BioMarin’s fourth quarter and full-year 2025 ...

Analysis

This announcement sets the date and access details for BioMarin’s fourth quarter and full-year 2025 results call on February 23, 2026 at 4:30 p.m. ET. Investors can look to this event for finalized 2025 figures following earlier preliminary updates, as well as discussion of recent debt financing for the Amicus acquisition and any commentary on prior ROCTAVIAN write-downs. Key focus areas include revenue trends, cash position, and forward guidance.

AI-generated analysis. Not financial advice.

SAN RAFAEL, Calif., Feb. 17, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Monday, February 23, 2026, at 4:30 p.m. ET to discuss fourth quarter and full-year 2025 financial results and provide a general business update.

Dial-in Number 
U.S. / Canada Dial-in Number: 800-715-9871
International Dial-in Number: 646-307-1963
Conference Call ID: 4503000  

U.S. / Canada Replay Dial-in Number: 800-770-2030
International Replay Dial-in Number: 609-800-9909
Playback ID: 4503000  

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, https://investors.biomarin.com/. A replay of the call will be archived on the site for one week following the call.

About BioMarin
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael, California-based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin pursues treatments that offer new possibilities for patients and families around the world navigating rare or difficult-to-treat genetic conditions. To learn more, please visit www.biomarin.com. 

Contacts:
Investors	Media
Traci McCarty	Marni Kottle
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(650) 374-2803

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-fourth-quarter-and-full-year-2025-financial-results-conference-call-and-webcast-on-monday-february-23-2026-at-430pm-et-302688803.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When is BioMarin's BMRN Q4 and full-year 2025 earnings call?

The call is scheduled for February 23, 2026 at 4:30 p.m. ET. According to BioMarin, Alexander Hardy will host and discuss fourth-quarter and full-year 2025 financial results and provide a general business update during the webcast and call.

How can investors access the BioMarin (BMRN) February 23, 2026 webcast?

Investors can access a live audio webcast via the BioMarin investor website. According to BioMarin, the webcast link is available at https://investors.biomarin.com and the replay will be archived on the site for one week.

What dial-in numbers are provided for BioMarin's February 23, 2026 conference call?

U.S./Canada dial-in is 800-715-9871 and international is 646-307-1963. According to BioMarin, the conference call ID is 4503000 and replay dial-in numbers and playback ID are also provided for one-week access.

Who will present on the BioMarin (BMRN) February 23, 2026 earnings call?

Alexander Hardy, President and CEO, will host the call and provide the business update. According to BioMarin, he will discuss the fourth-quarter and full-year 2025 financial results and answer related questions during the webcast.

How long will the replay of BioMarin's February 23, 2026 earnings call be available?

The replay will be archived on the investor website for one week following the call. According to BioMarin, both U.S./Canada and international replay dial-in numbers and a playback ID will be provided for access.